- Home
- TDTH vs NXL Comparison
TDTH vs NXL Comparison
Compare TDTH & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TDTH
- NXL
- Stock Information
- Founded
- TDTH 2014
- NXL 2010
- Country
- TDTH Singapore
- NXL United States
- Employees
- TDTH 23
- NXL N/A
- Industry
- TDTH
- NXL Medical Specialities
- Sector
- TDTH
- NXL Health Care
- Exchange
- TDTH NYSE
- NXL Nasdaq
- Market Cap
- TDTH 20.0M
- NXL 21.0M
- IPO Year
- TDTH 2024
- NXL 2022
- Fundamental
- Price
- TDTH $0.46
- NXL $1.03
- Analyst Decision
- TDTH
- NXL Strong Buy
- Analyst Count
- TDTH 0
- NXL 1
- Target Price
- TDTH N/A
- NXL $5.00
- AVG Volume (30 Days)
- TDTH 10.0M
- NXL 79.8K
- Earning Date
- TDTH 07-22-2025
- NXL 08-07-2025
- Dividend Yield
- TDTH N/A
- NXL N/A
- EPS Growth
- TDTH N/A
- NXL N/A
- EPS
- TDTH N/A
- NXL N/A
- Revenue
- TDTH $465,435.00
- NXL $131,065.00
- Revenue This Year
- TDTH N/A
- NXL $79.59
- Revenue Next Year
- TDTH N/A
- NXL $334.65
- P/E Ratio
- TDTH N/A
- NXL N/A
- Revenue Growth
- TDTH N/A
- NXL N/A
- 52 Week Low
- TDTH $0.17
- NXL $0.59
- 52 Week High
- TDTH $4.74
- NXL $4.49
- Technical
- Relative Strength Index (RSI)
- TDTH N/A
- NXL 43.50
- Support Level
- TDTH N/A
- NXL $0.96
- Resistance Level
- TDTH N/A
- NXL $1.10
- Average True Range (ATR)
- TDTH 0.00
- NXL 0.07
- MACD
- TDTH 0.00
- NXL 0.02
- Stochastic Oscillator
- TDTH 0.00
- NXL 60.87
About TDTH TRIDENT DIGITAL TECH HOLDINGS LTD SPON ADS EACH REP 8 ORD CL B
Trident Digital Tech Holdings Ltd is principally engaged in the provision of business consulting service and IT customization solutions in the Republic of Singapore. Its revenue is derived from business consulting service, IT customization and selling event tickets.
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.